327 related articles for article (PubMed ID: 31229162)
61. Primary cutaneous T-cell lymphomas.
Rosen ST; Querfeld C
Hematology Am Soc Hematol Educ Program; 2006; ():323-30, 513. PubMed ID: 17124079
[TBL] [Abstract][Full Text] [Related]
62. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
[TBL] [Abstract][Full Text] [Related]
63. [Diagnostics of primary cutaneous lymphomas].
Felcht M; Hillen U; Klemke CD
Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
[TBL] [Abstract][Full Text] [Related]
64. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
65. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
McCusker S; Ngu I
Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
[TBL] [Abstract][Full Text] [Related]
66. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
67. Cutaneous T-cell lymphoma: overview and nursing perspectives.
McCann SA
Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
[TBL] [Abstract][Full Text] [Related]
68. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Duvic M; Chiao N; Talpur R
J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
[No Abstract] [Full Text] [Related]
69. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
[TBL] [Abstract][Full Text] [Related]
70. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
Beltraminelli H
Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
[TBL] [Abstract][Full Text] [Related]
71. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: history and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL).
Bunn PA; Foss FM
J Cell Biochem Suppl; 1996; 24():12-23. PubMed ID: 8806090
[TBL] [Abstract][Full Text] [Related]
72. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
[TBL] [Abstract][Full Text] [Related]
73. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2019 Sep; 94(9):1027-1041. PubMed ID: 31313347
[TBL] [Abstract][Full Text] [Related]
74. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2016 Jan; 91(1):151-65. PubMed ID: 26607183
[TBL] [Abstract][Full Text] [Related]
75. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
76. [Epitheliotropic lymphomas: better identification for improved treatment].
Bagot M
Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
[TBL] [Abstract][Full Text] [Related]
77. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
78. Bridging the specialty gap: Update on primary cutaneous lymphomas.
Olsen EA; Hodak E; Geskin L; Scarisbrick J;
J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
[No Abstract] [Full Text] [Related]
79. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma.
Goyal A; Foss F
Expert Rev Anticancer Ther; 2024; 24(1-2):41-58. PubMed ID: 38224371
[TBL] [Abstract][Full Text] [Related]
80. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]